1. Home
  2. WVE vs CNXC Comparison

WVE vs CNXC Comparison

Compare WVE & CNXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$13.25

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Logo Concentrix Corporation

CNXC

Concentrix Corporation

N/A

Current Price

$33.91

Market Cap

2.1B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
CNXC
Founded
2012
1991
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.1B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
WVE
CNXC
Price
$13.25
$33.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
5
Target Price
$30.87
$69.00
AVG Volume (30 Days)
2.2M
1.3M
Earning Date
05-29-2026
04-15-2026
Dividend Yield
N/A
4.10%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,704,000.00
$9,825,771,000.00
Revenue This Year
N/A
$5.17
Revenue Next Year
$119.93
$2.51
P/E Ratio
N/A
N/A
Revenue Growth
149.43
2.15
52 Week Low
$5.28
$29.35
52 Week High
$21.73
$66.00

Technical Indicators

Market Signals
Indicator
WVE
CNXC
Relative Strength Index (RSI) 47.06 48.83
Support Level $12.53 $31.63
Resistance Level $14.56 $44.40
Average True Range (ATR) 0.79 1.85
MACD -0.04 0.60
Stochastic Oscillator 26.10 81.68

Price Performance

Historical Comparison
WVE
CNXC

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About CNXC Concentrix Corporation

Concentrix Corp is a technology and services company. It designs, implements, and manages end-to-end solutions, including customer experience process optimization, technology development and design engineering, front- and back-office automation, analytics, and business transformation services. The company serves clients across multiple industry verticals, helping them manage customer engagement and operational processes throughout the customer lifecycle. The company operates in a single operating segment. It generates revenue through the provision of technology and services under contractual arrangements. Geographically, the company generates the maximum revenue from the Philippines and the rest from India, the United States, Great Britain, Germany, Canada and Other countries.

Share on Social Networks: